Dr. Jason Ysasaga, M.D.
What this data tells you about Dr. Ysasaga
Dr. Jason Ysasaga is an ophthalmology in Amarillo, TX, with 20 years in practice. Based on federal Medicare data, Dr. Ysasaga performed 202,989 Medicare services across 13,332 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ysasaga received a total of $13,960 from 26 pharmaceutical and/or device companies across 117 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ysasaga is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Eye injection (Vabysmo/faricimab) | 165,855 | $29 | $60 |
| Injection, pegcetacoplan, intravitreal, 1 mg | 5,535 | $120 | $200 |
| Eye injection for retinal disease | 5,018 | $86 | $701 |
| Retinal imaging (OCT scan) | 4,878 | $29 | $160 |
| Office visit, established patient (30-39 min) | 4,611 | $87 | $300 |
| Exam of retinal blood vessels using a special camera after injection of a dye | 4,042 | $101 | $315 |
| Extended exam of the back part of the eye with optic nerve drawing | 2,882 | $12 | $75 |
| Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg | 1,855 | $173 | $780 |
| Extended exam of the back part of the eye with retinal drawing | 1,843 | $19 | $75 |
| Exam of blood vessels between the white part of eye and retina using a special camera after injection of a dye | 1,512 | $140 | $575 |
| Unclassified drugs | 986 | $1,760 | $7,500 |
| Injection, ranibizumab, 0.1 mg | 825 | $179 | $500 |
| Retinal photography (fundus photo) | 824 | $26 | $185 |
| Injection, dexamethasone, intravitreal implant, 0.1 mg | 497 | $158 | $300 |
| Exam of retinal blood vessels and blood vessels between the white part of eye and retina using a special camera after injection of a dye | 452 | $190 | $600 |
| Destruction of growth of retina using a laser | 208 | $387 | $1,625 |
| Destruction of leaking blood vessels of retina using laser | 170 | $253 | $2,740 |
| Compounded drug, not otherwise classified | 131 | $66 | $118 |
| Office visit, established patient (10-19 min) | 127 | $44 | $105 |
| New patient office visit (45-59 min) | 102 | $109 | $400 |
| 2d ultrasound scan of eye tissue and structures | 100 | $34 | $235 |
| Aflibercept eye injection (Eylea) | 92 | $653 | $1,500 |
| Comprehensive eye exam, established patient | 84 | $85 | $300 |
| Removal of membrane of retina with removal of internal limiting membrane of retina | 74 | $874 | $4,600 |
| Steroid injection (triamcinolone) | 64 | $1 | $40 |
| Removal of membrane of retina | 62 | $873 | $4,600 |
| Complex repair of detached retina and drainage of eye fluid between lens and retina | 35 | $999 | $4,350 |
| Removal of recurring cataract in lens capsule using a laser | 34 | $256 | $1,070 |
| Injection, bevacizumab, 10 mg | 32 | $49 | $115 |
| Office visit, established patient (20-29 min) | 18 | $70 | $200 |
| Injection of drug or substance into membrane covering eyeball | 16 | $40 | $245 |
| Photocoagulation treatment to prevent detachment of retina | 13 | $172 | $1,300 |
| 1d and 2d ultrasound scan of eye tissue and structures | 12 | $49 | $470 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (39%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 10% for ophthalmology in TX.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Ysasaga is a mixed practice specialist, with above-average Medicare volume (top 0% in TX), and high industry engagement (mixed engagement, top 10%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Ysasaga experienced with eye injection (vabysmo/faricimab)?
Does Dr. Ysasaga receive payments from pharmaceutical companies?
How do Dr. Ysasaga's costs compare to other ophthalmologys in Amarillo?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology